The role of endothelium-derived hyperpolarizing factor (EDHF) in either the healthy circulation or in those with hypercholesterolemia is unknown. In healthy and hypercholesterolemic subjects, we measured forearm blood flow (FBF) using strain-gauge plethysmography at rest, during graded handgrip exercise, and after sodium nitroprusside infusion. Measurements were repeated after l-NMMA, tetraethylammonium (TEA), and combined infusions. At rest, l-NMMA infusion reduced FBF in healthy but not hypercholesterolemic subjects. At peak exercise, vasodilation was lower in hypercholesterolemic compared to healthy subjects (274% vs 438% increase in FBF, p=0.017). TEA infusion reduced exercise-induced vasodilation in both healthy and hypercholesterolemic subjects (27%, p<0.0001 and -20%, p<0.0001, respectively). The addition of l-NMMA to TEA further reduced FBF in healthy (-14%, p=0.012) but not in hypercholesterolemic subjects, indicating a reduced nitric oxide and greater EDHF-mediated contribution to exerciseinduced vasodilation in hypercholesterolemia. In conclusion, exercise-induced vasodilation is impaired and predominantly mediated by EDHF in hypercholesterolemic subjects. Clinical Trial Registration Identifier: NCT00166166
Introduction
The endothelium plays a dynamic role in regulating vasomotor tone and blood flow in response to physiologic and chemical signals by releasing paracrine vasoactive factors that include nitric oxide (NO), prostacyclin, and endo-thelium-derived hyperpolarizing factors (EDHF). Even after inhibition of NO and cyclooxygenase, endothelium-dependent vasodilation persists, revealing the existence of a substantial NO-and prostaglandin-independent component that has been attributed to EDHF release. [1] [2] [3] [4] The hallmark of EDHF-mediated responses is their abolition by the combination of apamin (a specific inhibitor of K + Ca channels of small conductance vessels) plus charybdotoxin (a non-selective inhibitor of large-conductance and intermediate-conductance channels, as well as some voltagedependent K + channels), as noted in pre-clinical studies. 5, 6 Although potential EDHFs may differ by species and vascular bed, [6] [7] [8] [9] [10] they are thought to promote vasodilation via a common pathway of activation of calcium-dependent potassium (K + Ca ) channels. 11, 12 Recently, we demonstrated using tetraethylammonium chloride (TEA) -a specific K + Ca channel antagonist that EDHF contributes to both resting vasodilator tone and to bradykinin-stimulated vasodilation. 13, 14 Microvascular forearm vasodilation during exercise is a multi-factorial phenomenon that includes contribution from local muscle metabolites such as lactate, adenine nucleotides, acidosis, decreased tissue oxygen tension, increased carbon dioxide tension, and osmolality. 15 The magnitude of the contribution of NO and prostacyclin to exercise-induced vasodilation appears to be modest; inhibition of NO and prostacyclin causes an 11% and 13% reduction in exerciseinduced vasodilation, respectively. 2, [16] [17] [18] [19] [20] [21] [22] The contribution of EDHF to exercise-induced forearm microvascular vasodilation in humans remains unknown, with a variable contribution observed in previous studies in leg muscles. 16, 17 Importantly, the impact of cardiovascular risk factors that are known to impair NO activity on the contribution of EDHF to vasodilation during exercise remains unknown. [23] [24] [25] [26] [27] We investigated the contribution of NO and EDHF to exercise-induced forearm vasodilation in healthy humans and in those with hypercholesterolemia. We hypothesized that endothelium-dependent hyperpolarization contributes to exercise-mediated forearm microvascular vasodilation via activation of K + Ca channels, and that the contribution of NO and EDHF varies between the healthy and hypercholesterolemic vasculature.
Methods

Subjects
Twenty-six healthy individuals and 19 subjects with hypercholesterolemia aged between 21 and 60 years (47% male) were enrolled into two separate protocols ( Figure 1 ). All subjects were non-smokers and free from hypertension, cardiovascular disease, systemic disorders, and any oral medications. Pregnant females were excluded. Hypercholesterolemia was defined as a low-density lipoprotein (LDL)-cholesterol level of >140 mg/dL. The study was approved by the Emory University Institutional Review Board and all subjects provided informed consent.
Measurement of forearm blood flow at rest and during exercise
Measurements were performed after an overnight fast in a quiet temperature-controlled (22°C to 24°C) room. Subjects refrained from exercise, alcohol and caffeine for at least 24 hours previously. After insertion of an intra-brachial arterial cannula for arterial pressure monitoring and delivery of drug infusions, subjects received oral aspirin (975 mg) to inhibit prostacyclin synthesis at least 1 hour prior to the study. 28 Simultaneous forearm blood flow (FBF) measurements were obtained in both arms using a dual-channel venous occlusion strain-gauge plethysmograph (model EC6; DE Hokanson, Bellevue, WA, USA) as described previously. 19 Flow measurements were recorded for approximately 7 seconds, every 15 seconds up to eight times, and a mean FBF value in mL•min −1 •100 mL −1 was computed. Forearm vascular resistance (FVR) was calculated as the mean arterial pressure ÷ FBF and expressed as mmHg per mL•min −1 •100 mL −1 .
The instrumented forearm was exercised with intermittent handgrip by squeezing an inflated pneumatic bag, as previously described. 2, 29 Exercise was performed at 15%, 30%, and 45% of maximum voluntary grip strength, which was determined in each subject. Each contraction lasted for 5 seconds followed by relaxation for 10 seconds. The contraction-relaxation sequence was repeated for a total of 5 minutes at each workload and FBF measurements were made in the final 2 minutes at each workload. Preliminary Figure 1 . Study design. Aspirin (975 mg) was administered 1 hour prior to commencement of the study for cyclooxygenase inhibition. Forearm blood flow measurements were performed after handgrip exercise (15%, 30% and 45% of maximum grip strength) and after endothelium-independent vasodilation with intra-arterial sodium nitroprusside (SNP; 1.6, 3.2 µg/min). Measurements were repeated after l-NMMA (16 µmol/min) or TEA (1 µmol/min) and after combined blockade with l-NMMA and TEA.
studies and previous studies in our laboratory demonstrated that FBF remained constant after 2 minutes of exercise. 2 Protocol 1. All agents were administered intra-arterially after resting measurements were made during saline infusion (2.5 mL•min −1 ). To investigate the effect of inhibition of K + Ca channels without prior inhibition of NO on exercise-induced vasodilation, we studied 10 healthy and nine hypercholesterolemic subjects. FBF was measured during infusion of saline (1 mL•min −1 ), after exercise, and after intra-arterial infusions of the endothelium-independent vasodilator sodium nitroprusside at 1.6 and 3.2 mg/min for 8 minutes each ( Figure 1 ). After repeating resting flow measurements, FBF was measured during an 8-minute infusion of intra-arterial tetraethylammonium chloride (TEA; Clinalfa, Switzerland) at 1 mg/ min. While continuing the infusion of TEA, exercise was repeated as before. After a 30-minute rest period, FBF measurements were repeated during an 8-minute infusion of l-NMMA (Clinalfa) at 16 µmol/min to inhibit NO synthesis. While continuing l-NMMA and TEA infusions, exercise and infusions of sodium nitroprusside were repeated as before. The l-NMMA dose has been previously shown to be effective in attenuating resting and agonist-stimulated FBF. 2 When given at 0.25, 0.5 and 1 mg/min, TEA is known to selectively inhibit K + Ca channels, but it reduced FBF at rest and after bradykinin only at the highest rate of infusion in previous experiments. Also, at a 1 mg/min infusion rate, the intra-arterial concentration of <0.6 µmol/min is known to specifically inhibit K + Ca channels. 11,30-32 Arterial blood pressure and FBF measurements were repeated in the last 2 minutes of each intervention ( Figure  1 ). This protocol enabled measurements of the contribution of NO and combined NO and EDHF blockade on exerciseinduced vasodilation. Protocol 2. To investigate the effect of inhibition of K + Ca channels after NO inhibition on exercise-induced vasodilation, protocol 1 was repeated in separate experiments in 16 healthy and 10 hypercholesterolemic subjects. During saline infusions, FBF was measured at rest, after graded handgrip exercise, and after infusions of sodium nitroprusside. Measurements were repeated after an 8-minute infusion of l-NMMA at 16 µmol/min followed by exercise. This was followed by the addition of TEA to the l-NMMA. FBF was repeated at rest, after graded exercise, and after sodium nitroprusside infusions ( Figure 1 ). Arterial blood pressure and FBF were measured in the last 2 minutes of each intervention.
Contribution of K + Ca channel activation and NO to exercise-induced vasodilator tone
Statistical analysis
FBF and FVR were log-transformed into a normal distribution. The effects of l-NMMA and TEA on resting FBF and FVR with single and combined blockade within each group (healthy and hypercholesterolemic) were then compared using linear mixed effects modeling for repeated measures, with the blocker (TEA or l-NMMA or combined blockade) as a fixed effect. Similarly, to assess the impact of blockade on exercise-induced vasodilation, FBF and FVR were compared between healthy and hypercholesterolemic subjects using linear mixed effects modeling for repeated measures, with the group (healthy or hypercholesterolemic), blocker (l-NMMA, TEA or combined blockage) and exercise intensity as fixed effects. All comparisons were adjusted for age, sex, race, body mass index (BMI), mean arterial pressure and baseline FBF or FVR. The Bonferroni correction was used to adjust for multiple comparisons. Data in the text are presented as mean ± SD and as mean ± SEM in the figures. A value of p<0.05 was considered statistically significant.
Results
Baseline characteristics
Hypercholesterolemic subjects had higher total and LDLcholesterol and triglyceride levels. They were also older, had a higher diastolic blood pressure and a greater BMI compared to healthy subjects (Table 1) . 
Effects of l-NMMA and TEA on resting vasodilator tone
There were no significant differences in baseline FBF and FVR between healthy and hypercholesterolemic subjects. FBF decreased and FVR increased significantly with l-NMMA in healthy individuals (p<0.001 for both) but not in hypercholesterolemic subjects (p=0.3 for FBF; p=0.4 for FVR) ( Figure 2 ). In contrast, TEA did not change the FBF (p=0.2) or FVR (p=0.2) significantly in healthy individuals, but decreased FBF (p=0.018) and increased FVR (p=0.037) in hypercholesterolemic subjects compared to baseline ( Figure 2 ). Combined blockade of NO and K + Ca with l-NMMA and TEA led to additional vasoconstriction in both groups independent of the order of administration of the antagonists, with a lower FBF and higher FVR (p<0.001 for both) (Figure 2 ). As previously described, these findings indicated that, in comparison to healthy individuals, the contribution of NO to resting vasodilator tone is lower in hypercholesterolemic subjects and is partially compensated by an increased contribution of EDHF. 13 
Exercise-induced vasodilation in healthy and hypercholesterolemic subjects
Handgrip exercise produced increasing vasodilation that was similar at the lower two levels of exercise (15% and 30% of maximal handgrip) in both groups, but was lower at peak exercise (45% of maximal handgrip) in hypercholesterolemic compared to healthy subjects (change in FBF: +274% vs +438%, p=0.017; FVR: -69% vs -78%, p=0.004, respectively) ( Figure 3 ). Throughout the experiments, the handgrip exercise did not cause significant change in mean arterial blood pressure, heart rate, or blood flow in the contralateral control arm.
Effect of TEA alone and in combination with l-NMMA on forearm vascular tone during exercise
Healthy subjects (n=10). Exercise-induced vasodilation was attenuated by TEA in the absence of l-NMMA; mean FBF was 27.3% (p<0.0001) lower and mean FVR increased 41.6% (p<0.0001), indicating the important contribution of K + Ca channel activation (i.e. EDHF activity) to exercise-mediated microvascular dilation ( Figure 4A, 4C ). Exercise-induced vasodilation was further attenuated after addition of l-NMMA to TEA, with an additional 13.6% (p=0.012) reduction in mean FBF and 20.6% (p=0.0004) increase in mean FVR compared with TEA infusion alone ( Figure 4A, 4C ).
Hypercholesterolemic subjects (n=9). Infusion of TEA alone attenuated exercise-induced vasodilation in hypercholesterolemic subjects; mean FBF was reduced by 20.3% (p<0.0001) and mean FVR was increased by 24.9% (p<0.0001) ( Figure 4B, 4D ). However, co-infusion of l-NMMA with TEA produced no further reduction in exercise-stimulated vasodilation (p=0.5), indicating a decreased contribution of NO in subjects with hypercholesterolemia in whom K + Ca channel activity was preserved.
Effect of l-NMMA alone and in combination with TEA on forearm vasodilation during exercise
Healthy subjects (n=16). l-NMMA attenuated exerciseinduced vasodilation with a 19.3% (p<0.0001) lower mean FBF, and a 36.5% (p=0.0007) higher mean FVR ( Figure  5A, 5C ). Exercise-induced vasodilation was further attenuated after the addition of TEA to l-NMMA, with an additional 8.5% (p=0.002) reduction in mean FBF and 11.7% (p=0.0001) increase in mean FVR compared with l-NMMA infusion alone ( Figure 5A, 5C ).
Hypercholesterolemic subjects (n=10). l-NMMA attenuated exercise-induced vasodilation with a 17.6% (p=0.0001) lower mean FBF and a 35.9% (p=0.0006) higher mean FVR ( Figure 5B, 5D ). Exercise-induced vasodilation was further attenuated after the addition of TEA to l-NMMA, with an additional 18.3% (p=0.005) reduction in mean FBF and a 17.5% (p=0.02) increase in mean FVR compared with l-NMMA infusion alone ( Figure 5B, 5D ). The reductions in exercise-induced vasodilation with NO blockade and with the addition of TEA were similar in magnitude to that observed in healthy subjects.
Vasodilator responses to sodium nitroprusside
Infusion of sodium nitroprusside produced a stepwise vasodilator response that was similar (FBF, p=0.37; FVR, p=0.70) in healthy and hypercholesterolemic subjects. Combined infusions of l-NMMA and TEA did not alter forearm vasodilation with sodium nitroprusside. Age, sex, systolic blood pressure and BMI did not influence the results of NO or K + Ca channel inhibition.
Discussion
Herein we demonstrate that both NO and K + Ca channel activation (EDHF) contribute equally and in concert to exercise-induced microvascular vasodilation in the healthy human forearm circulation. Dual inhibition of these endothelium-derived factors caused further inhibition of microcirculatory vasodilation during exercise, demonstrating the independent and additive contribution of NO and EDHF to physiologic vasodilation. In contrast, in hypercholesterolemia, K + Ca channel activation appeared to be the predominant mechanism for exercise-induced vasodilation; after K + Ca channel blockade, inhibition of NO had no further effect on the vasodilator response to exercise in these subjects. Finally, the lack of inhibition of sodium nitroprusside-mediated endothelium-independent vasodilation by l-NMMA and TEA indicates that the blockade observed during exercise with these antagonists was specifically endothelium-dependent.
NO and exercise-induced vasodilation
The mechanisms underlying exercise-induced vasodilation are complex and the understanding of the potential mediators remains incomplete. Skeletal muscle blood flow increases in proportion to the metabolic demand. [33] [34] [35] [36] [37] The precise contribution of the various vasoactive compounds to exercise-induced vasorelaxation may also differ by muscle beds studied and involve the interaction of the autonomic nervous system. [37] [38] [39] [40] Prostacyclins contribute modestly and transiently to exercise-induced vasodilation 20 and, for the purposes of this study, cyclooxygenase was inhibited prior to the study. Previous studies have either shown modest inhibition of exercise hyperemia with NO blockade 2, 17, 20 or have failed to demonstrate any contribution of NO to exercise, 21, 41, 42 raising the concept of redundancy, where compensatory release of other vasodilators may explain the lack of effect of NO inhibition. 16 Differences in experimental methods, sample size, and muscle beds examined may also account for the differences. 21, 41, 42 Herein, we have demonstrated a 19.3% reduction in mean vasodilation in response to exercise in healthy individuals after inhibition of NO, consistent with, or more pronounced than the 11% reduction observed previously. 2 This difference may be due to the comparatively younger age and consequently greater NO activity in the current healthy cohort. There was a contribution of NO to exercise-induced vasodilation even after K + Ca channel blockade, with a further 13.6% reduction in flow with l-NMMA in healthy subjects. This confirms the importance of NO in physiological vasodilator responses and demonstrates it is additive to the contribution of K + Ca channel activation.
EDHF and exercise-induced vasodilation in healthy subjects
In a previous study of seven healthy subjects, inhibition of cytochrome P450 2C9 with sulphaphenazole did not alter exercise-induced vasodilation in thigh muscles, suggesting lack of contribution of epoxyeicosatrienoic acids to exercise hyperemia. 16 Our results provide the first evidence for the contribution of EDHF, and in particular of K + Ca channel activation, to physiological vasodilation of the forearm microvasculature during exercise. We have demonstrated a 27.3% reduction in exercise-induced vasodilation with TEA, even in the absence of inhibition of NO, and an additional reduction in FBF with TEA after NO blockade. Taken together with the findings of the previous study, it would appear that EDHFs stimulated by exercise that lead to K + Ca channel stimulation may not be cytochrome P450-derived peptides, and potentially involve hydrogen peroxide and other EDHF mechanisms. In contrast to our findings, Mortensen et al. failed to demonstrate an effect of K + Ca channel blockade with TEA when measuring blood flow changes in response to leg exercise. 17 Variations in muscle beds studied and techniques (thermodilution versus plethysmography) may have accounted for the observed differences. The intravascular concentration of TEA (0.5 mmol/L) used was similar in this study, and has previously been demonstrated to specifically inhibit K + Ca channels. 30, [43] [44] [45] [46] The contribution of both NO and K + Ca channel activation to exercise hyperemia was similar in magnitude in the healthy subjects. This was unexpected based on experimental studies, demonstrating that the contribution of EDHF is only evidenced after NO blockade. 16, [46] [47] [48] Even after inhibition of NO with l-NMMA, K + Ca channel activation continued to contribute to exercise-induced microvascular dilation. Similarly, after the initial inhibition of K + Ca channels with TEA, further inhibition of exercise-vasodilation with l-NNMA was observed, with an additional 13.6% reduction in mean exercise flow, suggesting an independent and additive effect of dual blockade.
EDHF and exercise-induced vasodilation in hypercholesterolemia
In hypercholesterolemic subjects, the attenuation of exercise-induced vasodilation after NO blockade, when EDHF was not inhibited, was similar to the responses observed in healthy subjects, suggesting that NO contributes to physiologic vasodilation. This is consistent with our previous observations of preserved endothelium-dependent vasodilation with bradykinin in hypercholesterolemia. 13 However, in contrast to healthy subjects and the effects on bradykinin responses, after EDHF blockade with TEA, no further attenuation of exercise-induced vasodilation was observed with NO blockade in subjects with hypercholesterolemia. This suggests that in vasculature exposed to hypercholesterolemia, K + Ca channel activity may be the predominant mechanism for exercise-induced vasodilation. It also suggests that NO and K + Ca channels may interact such that inhibition of K + Ca channels may inhibit the NO pathway in hypercholesterolemia, an observation that needs further investigation.
We have further demonstrated that hypercholesterolemic individuals have an attenuated forearm vasodilator response to exercise at the highest handgrip effort when compared to healthy individuals. Also, in contrast to the healthy microvasculature, there is a lack of contribution of NO to exercise-induced vasodilation after K + Ca channel blockade, and this NO deficiency may contribute to the lower vasodilator response in the hypercholesterolemic subset. This reduction of NO activity was as a result of decreased NO production or availability and not from vascular smooth muscle dysfunction, as the sodium nitroprusside responses were similar in both groups.
It may be argued that the reduced vasodilation observed during exercise with l-NMMA and TEA is due to the vasoconstrictor effect of these antagonists on resting tone. However, resting vasoconstriction was entirely overcome by the endothelium-independent vasodilator sodium nitroprusside. Thus, if an endothelium-independent stimulus were entirely responsible for the exercise-induced vasodilation, then exercise hyperemia would also be expected to overcome the effect of the inhibitors on resting vascular tone. Limitations. Our findings are limited to the forearm microcirculation and thus other vascular beds, including conductance arteries, warrant further investigation. Nevertheless, it is known that the contribution of EDHF is less in conductance vessels than in the microvessels. 8, 12, 49 Second, l-NMMA and TEA are competitive inhibitors and may not completely inhibit NO and K + ca channels and thus may underestimate the importance of these mediators in vivo. Third, other endothelium-derived vasoactive mediators to exercise hyperemia may also play a compensatory role after the blockade of NO and K + Ca channels and need to be investigated. 37 Fourth, our investigations were conducted on a background of cyclooxygenase inhibition. Although we have previously demonstrated that vasodilator prostanoids contribute to resting vasodilator tone, we found that cyclooxygenase products did not contribute to the endothelial dysfunction of hypertensive or hypercholesterolemic patients. 50 Fifth, we employed an intermittent isometric handgrip exercise that produced no systemic hemodynamic changes. Other muscle beds and different intensities of exercise that alter shear stress variably will need to be explored in future studies. 51, 52 The older age and higher BMI in our hypercholesterolemic subjects may have also contributed to the observed abnormalities, but statistical correction for these factors did not alter our findings. Finally, we measured blood flow with plethysmography immediately after terminating handgrip exercise, and thus report on flow during early recovery from exercise.
Conclusions
We have demonstrated an important contribution of EDHF, via the activation of K + Ca channels, to forearm microvascular vasodilation during exercise in healthy subjects with a greater contribution compared to NO in hypercholesterolemic subjects. Whether enhancing EDHF in conditions with impaired NO activity would be of therapeutic value, and whether agents that improve endothelial dysfunction, such as statins and angiotensin antagonists, also enhance EDHF bioactivity remains to be studied.
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